Boswellia extract (acetyl-11-keto-beta-boswellic acid, AKBA)
Boswellia Serrata Extract (AKBA / ApresFlex) · also known as Boswellic acids, AKBA, ApresFlex, 5-Loxin
In vitro, AKBA can inhibit 5-lipoxygenase (5-LOX). A human randomized trial showed that 5-Loxin can lower synovial fluid MMP-3, but plasma LTB4 did not fall after oral boswellia extract. Its anti-inflammatory mechanism and cartilage-repair effects in humans have not been confirmed.
Clinical uses and human evidence
Osteoarthritis pain
Studies (2)
- Karlapudi 2023 · J Am Nutr Assoc · RCT · n=70 — Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Kumar 2025 · J Am Nutr Assoc · RCT · n=80 — A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study
Inflammation markers (such as CRP)
Diarrhea (including antibiotic-associated diarrhea)
Mechanisms of action
Joint cartilage matrix glycan (GAGs/Aggrecan) repair and lubrication
In one randomized controlled trial, 5-Loxin lowered synovial fluid MMP-3, which supports a regulatory effect on pathways linked to cartilage matrix breakdown. However, this result does not yet show that cartilage structure regenerates, and it cannot be attributed to AKBA alone.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
Findings of direct inhibition of IκB kinase (IKK) and blocking of NF-κB entry into the nucleus come mainly from in-vitro experiments at micromolar concentrations, and from cell and animal models. It is unclear whether free AKBA reaches effective concentrations at usual doses, and inflammation outcomes in humans cannot show that this target is responsible.
Direct inhibition of cyclooxygenase and lipoxygenase (COX-2 / 5-LOX) activity
In vitro, AKBA can inhibit 5-LOX, thereby reducing leukotriene synthesis. However, plasma protein binding and low human exposure limit extrapolation to routine oral use, and plasma LTB4 also did not fall after oral boswellia extract. The degree of 5-LOX inhibition in humans is uncertain, and it cannot be claimed that there is no effect on COX-1 or the gastric mucosa.
Collagen triple-helix cross-linking and fibril synthesis
The fall in synovial fluid MMP-3 suggests that pathways involved in cartilage matrix breakdown may be modulated, but this result does not prove increased collagen synthesis or cross-linking. There is no human evidence for the collagen renewal this mechanism refers to.